Selective Thionation of Pomalidomide Using Phosphorus Pentasulfide
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The existing method for synthesizing 3,6′-dithiopomalidomide from pomalidomide using Lawesson's reagent is inefficient due to low yield, high production costs, and the difficulty in separating high-purity 3,6′-dithiopomalidomide from its isomer 1,6-dithiopomalidomide, which results in unacceptably low yields and high separation costs.
Innovation Solution
A method involving the use of phosphorus pentasulfide (P2S5) as a thionating agent, where pomalidomide is dissolved in a solvent like dioxane, stirred at 105° C to 115° C for 20 to 120 minutes, and then purified to selectively increase the yield of 3,6′-dithiopomalidomide to 90% or more, reducing the production of 1,6-dithiopomalidomide and simplifying the purification process.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If Lawesson's reagent is used for thionation of pomalidomide, then the reaction can proceed, but the yield is low and 1,6'-dithiopomalidomide is produced as major product
Solution Approach 1:
The patent changes the chemical parameters of the thionation reaction by replacing Lawesson's reagent with phosphorus pentasulfide (P2S5) as the thionating agent. This parameter change fundamentally alters the reaction pathway and selectivity, enabling preferential thionation at the 3' position to produce 3,6'-dithiopomalidomide as the major product with high yield, resolving the selectivity-yield contradiction.
2Ease of manufacture
If Lawesson's reagent is used, then thionation reaction occurs, but strong odor and foul-smelling by-products are generated
Solution Approach 1:
The patent replaces Lawesson's reagent with phosphorus pentasulfide (P2S5), which is a more stable, less odorous, and commercially available reagent. P2S5 does not produce foul-smelling by-products and can be handled more easily, eliminating the harmful odor issue while maintaining reaction effectiveness.
3Ease of manufacture
If Lawesson's reagent is used, then thionation can be performed, but purification is complicated and time-consuming
Solution Approach 1:
By changing the thionating agent from Lawesson's reagent to phosphorus pentasulfide (P2S5), the reaction selectivity parameter is improved, causing 3,6'-dithiopomalidomide to be produced as the major product. This eliminates the need for complex separation processes to remove 1,6'-dithiopomalidomide, significantly reducing purification time and complexity.
4Ease of manufacture
If Lawesson's reagent is used, then reaction proceeds, but production cost is high
Solution Approach 1:
The patent substitutes expensive Lawesson's reagent with phosphorus pentasulfide (P2S5), which is a cheaper, commercially available reagent. Combined with the improved yield and reduced purification costs, this substitution significantly lowers the overall production cost of 3,6'-dithiopomalidomide.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method significantly increases the yield and economic feasibility of 3,6′-dithiopomalidomide production by preferentially thionating the carbonyl group at the 3′ position, reducing the time and cost required for separation and achieving high-purity 3,6′-dithiopomalidomide.
Implementation Method 1
a second step of adding phosphorus pentasulfide (P2S5) to the dissolved pomalidomide, followed by stirring
Data Source
AI summary
In a method of synthesizing 3,6′-dithiopomalidomide from pomalidomide according to an embodiment, pomalidomide is dissolved by adding a solvent thereto, phosphorus pentasulfide (P2S5) is added to the dissolved pomalidomide, followed by stirring, and solids are removed from the stirred solution, followed by purification. It is possible to reduce the production of 1,6-dithiopomalidomide, which is a by-product produced during the synthesis of 3,6′-dithiopomalidomide, and selectively increase the proportion of 3,6-dithiopomalidomide among synthesized isomeric compounds to 90% or more, thereby reducing the time and cost required to separate 1,6-dithiopomalidomide by HPLC, etc. in a subsequent purification process, thereby increasing the production and economic feasibility of the 3,6′-dithiopomalidomide compound.